ZAZZI MAURIZIO | Elenco docenti

Amodeo, D., Marchi, S., Fiaschi, L., Raucci, L., Biba, C., Salvestroni, V., et al. (2025). Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm). APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 91(6) [10.1128/aem.00403-25]. - dettaglio
Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Rossetti, B., Ferrara, M., Taramasso, L., Bai, F., Lombardi, F., Ciccarelli, N., et al. (2025). Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial. INFECTIOUS DISEASES AND THERAPY, 14(1), 293-304 [10.1007/s40121-024-01083-1]. - dettaglio
Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - dettaglio
Martina, M.G., Vagaggini, C., Dreassi, E., De Angelis, M., Nencioni, L., Dragoni, F., et al. (2025). Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-14001-3]. - dettaglio